1. Mu Y, Shen SG, Shen YZ. Recent developments of study on portal hypertensive gastric mucosal lesions. Chinese Journal of Genetical Surgery 1993; 2:114-117
2. Li DG, Lu HM, Li XH, Chen JW, Jiang ZM, Wang XL, et al. Use of calcium-channel blockers in cirrhotic patients with portal hypertension. National Medical Journal of China 1990; 70: 370-374
3. Li DG, Xia WX, Lu HM, Li XH, Jiang ZM, Qiang QZ, et al. Significance of serum procollagen-III-peptide in replecting the therapeutic effects of calcium-channel blockers on heptic fibrosis. Chinese Journal of International Medicine 1990; 29: 453-456
4. Mu Y, Shen YZ, Chu YF, Zheng JL, Zhang MZ. Radoimmunoassay of gastric mucosal prostaglandin E2 in portal hypertensive rats with cirrhosis. Acta Academiae Medicinae Xuzhou 1992; 12: 299-301
5. Zhan MC, Zhang JF. Effect of intra-cerebroventricular injection of pentagastrin on gastric mucosal blood flow in rats. Chinese Journal of Digestion 1990; 10: 335-337